Showing results (1031-1040 of 1,525) with videos related to

Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|December 1, 2025
A Nonparametric Population Pharmacokinetic Model of Selumetinib in Pediatric Patients Diagnosed With Neurofibromatosis-I or Plexiform NeurofibromasZoltán Köllő, Janka Kovács, Michael N Neely, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 23, 2026
Preclinical Modeling and Simulation to Explore the Tissue/Plasma Exposure and Pharmacodynamic Effect of Vildagliptin in Diabetes TreatmentBruna Bernar Dias, Laura Ben Olivo, Bibiana Verlindo de Araújo
CPT: Pharmacometrics & Systems Pharmacology|November 25, 2025
B Cell Differentiation Model for Identifying Predictors of Responses to Rituximab-Mediated B Cell Depletion in Rheumatic DiseasesTomohisa Nakada, Donald E Mager
CPT: Pharmacometrics & Systems Pharmacology|November 12, 2025
Population Pharmacokinetics of Asundexian in People at Risk for Thromboembolic/Cardiovascular EventsAshraf Yassen, Friederike Kanefendt, Jochen Zisowsky, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2025
Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and ChallengesJames W T Yates, Michael Zientek, Kunal S Taskar, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 17, 2025
A Model-Based Meta-Analysis Framework Quantifying Drivers of Placebo Response in Atopic Dermatitis TrialsJean C Serrano, John Maringwa, Roel Straetemans, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 16, 2025
Neural Controlled Differential Equation and Its Application in Pharmacokinetics and PharmacodynamicsZhisong Wu, Pingyao Luo, Rong Chen, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2025
Predictors of Ability to Work in Multiple SclerosisGustaf J Wellhagen, Sebastian Ueckert, Elisabet Nielsen, et al.
Pageof 153